03:18 PM Abstract No. 15 Lutonix below-the-knee global drug-coated balloon IDE study: primary endpoint outcomes at 6 months and safety subgroup analyses

The most common clinical presentation of peripheral artery disease (PAD) comprises intermittent claudication though about one third of patients will progress to below-the-knee critical limb ischemia. Currently, percutaneous transluminal angioplasty (PTA) is the standard endovascular therapy employed in this patient population. The Lutonix BTK  IDE multicenter randomized study was conducted to assess the safety and efficacy of the Lutonix DCB for the treatment of stenosis or occlusion of native below-the-knee arteries.

Source: Journal of Vascular and Interventional Radiology : JVIR - February 23, 2019 Category: Radiology Authors: P. Geraghty Tags: Scientific Session 2: Finish the Race Source Type: research